Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation. 1996

M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
Gastroenterology Department, Hospital Clinic, University of Barcelona, Barcelona, Spain.

OBJECTIVE Nitric oxide, which is quenched by hemoglobin, has been implicated in the pathogenesis of portal hypertension. The aim of this study was to investigate the effects of increasing blood hemoglobin concentration by erythropoietin treatment on the gastrointestinal vasodilation associated with portal hypertension. METHODS Portal-hypertensive and sham-operated rats treated with erythropoietin were studied 2 weeks after surgery. Hemodynamic and rheological parameters were measured in baseline conditions and after N(G)-nitro-L-arginine methyl ester (L-NAME) or sodium nitroprusside treatment. RESULTS In portal-hypertensive rats, erythropoietin attenuated the increase in gastric mucosal and superior mesenteric artery blood flows and the decrease in arterial blood pressure and splanchnic vascular resistances. Those parameters were not affected by erythropoietin in sham-operated rats. A direct vascular effect of erythropoietin was ruled out by the lack of changes in blood pressure or mesenteric blood flow after intravenous erythropoietin administration and by a similar in vitro relaxation to acetylcholine in mesenteric artery rings. In portal-hypertensive rats, erythropoietin blunted the blood pressure response to sodium nitroprusside and attenuated the gastric and mesenteric blood flow response to L-NAME. CONCLUSIONS Gastrointestinal vasodilation associated with portal hypertension can be attenuated by increasing blood hemoglobin concentration. Inactivation of overproduced NO by hemoglobin may account for this effect.

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous

Related Publications

M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
January 2007, Hepatology research : the official journal of the Japan Society of Hepatology,
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
April 1999, Hepatology (Baltimore, Md.),
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
December 1993, Circulation,
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
October 1998, Hypertension (Dallas, Tex. : 1979),
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
August 1982, European journal of clinical investigation,
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
June 2005, American journal of respiratory cell and molecular biology,
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
September 1996, Journal of hepatology,
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
April 1997, Digestive diseases and sciences,
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
October 1996, Gastroenterology,
M Casadevall, and J M Piqué, and I Cirera, and E Goldin, and I Elizalde, and J Panés, and M A Martínez-Cuesta, and J Bosch, and J Terés, and J Rodés
July 1996, Journal of hepatology,
Copied contents to your clipboard!